π Takeda plants dengue vaccine in India playbook
Takeda Pharmaceutical is leveraging its new dengue vaccine, Qdenga, as a key growth area in India. The company plans to launch Qdenga in the first half of calendar 2027 across India. Dengue cases are a massive issue, with 233,519 reported cases in 2024 alone. Initially, sales will be private, aiming later for the National Immunisation Programme. Takeda is also investing in local production to ensure broad and equitable access to the vaccine. π